Canopy Growth Corporation - Common Shares (CGC)

NEW YORK — Tilray Brands, Inc. (NASDAQ:TLRY) delivered a resounding message to the market this week, reporting a record-breaking $206.7 million in net revenue for its fiscal 2026 third quarter. The results, released on April 1, 2026, showcase a company successfully navigating a complex global landscape by pivoting toward

In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the company delivered a "record" revenue performance of $206.7 million, outstripping analyst estimates of $201.3 million, it fell significantly

The main reason for investing in Canopy Growth over the years has been due to the hope that the U.S. might legalize marijuana.

These stocks aren't nearly as cheap as they look.

Shares of Canopy Growth have crashed more than 99% in the past five years.

Owning Canopy Growth has been a roller-coaster ride, and you may be sitting on huge losses.

It's a lot closer to it than it was a few years ago.

Sometimes it is best to just move on when an investment doesn't pan out as well as you hoped.

The company is renowned for consistently paying a high-yield dividend.

Canopy Growth is a penny stock for a reason, so only the most aggressive investors should even be looking at it.

Canopy Growth grows marijuana, but it hasn't been the best steward of investor capital.

Don't bet on either one to pull that off.

Constellation Brands (NYSE: STZ), the titan of Mexican beer imports and premium spirits, finds itself at a critical crossroads. After a decade defined by the explosive ascent of Modelo Especial—which famously dethroned Bud Light as America’s top-selling beer—the company is now grappling with a sobering reality. On February 12, 2026, Constellation announced a major leadership [...]

The cannabis company's shares have plummeted by more than 40% over the past year.

Sometimes, you need to know when to quit.

Institutions bought this cannabis stock ahead of rescheduling progress, but did they sell on the news?

The stock isn't nearly as cheap as it looks.

Canopy Growth's third-quarter earnings results come out next week.

Be careful not to catch a falling knife.

Canopy Growth's stock got a boost last month due to the recent developments in the cannabis industry.

As of January 9, 2026, the cannabis sector finds itself at a historic crossroads, caught between the euphoria of federal progress and the harsh reality of market mechanics. Following a landmark Executive Order in late 2025 aimed at accelerating the rescheduling of marijuana, the industry has entered the new year

Don't get your hopes up.

The marijuana business just got a little easier in America -- and maybe a whole lot more profitable.